Logo image
Iron status in toddlerhood predicts sensitivity to psychostimulants in children
Journal article   Peer reviewed

Iron status in toddlerhood predicts sensitivity to psychostimulants in children

Catharyn A Turner, Diqiong Xie, Bridget M Zimmerman and Chadi A Calarge
Journal of attention disorders, Vol.16(4), pp.295-303
05/2012
DOI: 10.1177/1087054710385067
PMCID: PMC3556512
PMID: 20978274

View Online

Abstract

Iron deficiency is associated with impaired dopaminergic signaling and externalizing behavior. The authors examine, whether iron stores in toddlerhood influence later response to psychostimulants. Youth participating in a study monitoring the long-term safety of risperidone were included in this analysis if they had received psychostimulant monotherapy for at least 3 weeks and had a complete blood count obtained before psychostimulant treatment. Sensitivity to psychostimulants was defined based on the weight-adjusted dose during the 1st year of treatment. Regression analysis examined whether the hematological tests based on the characteristics of red blood cells were associated with sensitivity to psychostimulants. A total of 29 participants (93% men; 76% Whites), primarily with ADHD (93%), comprised the current sample. The hematological tests were obtained, on average, 3 years before the initiation of psychostimulants monotherapy that occurred at 5.8 years of age and continued for a median of 0.85 years, at an average daily dose of 0.98 mg/kg (SD = 0.38) in methylphenidate equivalent. Compared with those who were poorly sensitive to psychostimulants, after adjusting for age, mean corpuscular volume was significantly higher in the highly and moderately psychostimulants sensitive groups. If replicated, these findings suggest that more attention should be paid to optimizing body iron in early childhood.
Humans Child, Preschool Infant Male Treatment Outcome Attention Deficit Disorder with Hyperactivity - drug therapy Anemia, Iron-Deficiency - blood Central Nervous System Stimulants - therapeutic use Risperidone - therapeutic use Antipsychotic Agents - therapeutic use Methylphenidate - therapeutic use Female Child

Details

Metrics

48 readers on Mendeley
Logo image